Health Outcome | All Studies | Studies Controlling for All Four Key Confounders | |||
---|---|---|---|---|---|
 | Summary Estimate OR (95% CI) | p-Value Hetero-geneity | Summary Estimate OR (95% CI) | p-Value Hetero-geneity | Attributable Risk Proportion# |
Bronchitis | 1.45 (1.34 - 1.56) | < 0.0001 | 1.45 (1.32 - 1.59) | 0.12 | 8.3 - 18.4% |
Respiratory infection group | 1.44 (1.32 - 1.58) | < 0.0001 | 1.44 (1.31 - 1.59) | < 0.0001 | Â |
Respiratory infections excluding otitis media | 1.43 (1.31 - 1.56) | < 0.0001 | 1.40 (1.29-1.52) | < 0.0001 | Â |
Respiratory infections excluding common cold and nonspecific upper respiratory infections | 1.42 (1.26 - 1.60) | 0.01 | 1.50 (1.32 - 1.70) | 0.07 | 9.1 - 20% |
Common cold or acute upper respiratory infection | 1.38 (1.21 - 1.57) | 0.009 | 1.38 (1.13 - 1.67) | 0.002 | Â |
Respiratory infections (children or infants) | 1.48 (1.34 - 1.62) | 0.16 | 1.48 (1.33 - 1.65) | 0.09 | 8.8 - 19.4% |
Respiratory infections (adults) | 1.50 (1.22 - 1.83) | < 0.0001 | 1.49 (1.14 - 1.95) | < 0.0001 | Â |